What drove GV.PA stock’s heavy volume today?

GV.PA stock volume spiked to **38,489,238** shares, driven by speculative flows and repositioning in a low-float micro-cap. High relative volume increased volatility and widened intraday price range between **€0.0015** and **€0.0020**.

What is Meyka AI’s current rating for GV.PA stock?

Meyka AI rates GV.PA with a score of **58.59/100**, Grade **C+** and a **HOLD** suggestion. The grade factors in benchmark comparisons, sector metrics, financial growth and analyst signals.

What are the main risks for GV.PA stock investors?

Key risks for GV.PA stock include low liquidity, negative EPS (**-0.11**), tight current ratio (**0.91**), negative interest coverage and potential dilution. Funding or operational setbacks could pressure the share price further.

What price targets does Meyka AI give for GV.PA stock?

Meyka AI's model cites a near-term reference target **€0.0040** and a 12-month scenario **€0.0100**, versus the current price **€0.0018**. These are model projections and not guarantees.

EU Stocks

GV.PA Genomic Vision SA EURONEXT: Most active €0.0018 Feb 2026, watch liquidity

ByDanny Kontos February 5, 2026

The GV.PA stock closed the EURONEXT session at €0.0018 on 04 Feb 2026 after heavy trading, making it one of Europe’s most active small caps today. Volume finished at 38,489,238 shares, more than double the 14,217,513 average, driving a 5.88% intraday rise from the previous close. Investors are watching liquidity and valuation closely because market cap stands at only €693,191.00 while the 50-day average price is €0.004844 and the 200-day average is €0.013997.